Sarepta Therapeutics Inc (SRPT)
127.39
+3.14
(+2.53%)
USD |
NASDAQ |
Apr 25, 16:00
127.36
-0.03
(-0.02%)
After-Hours: 20:00
Sarepta Therapeutics Total Long Term Debt (Quarterly): 1.238B for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.238B |
September 30, 2023 | 1.237B |
June 30, 2023 | 1.236B |
March 31, 2023 | 1.234B |
December 31, 2022 | 1.544B |
September 30, 2022 | 1.543B |
June 30, 2022 | 1.101B |
March 31, 2022 | 1.099B |
December 31, 2021 | 1.097B |
September 30, 2021 | 1.095B |
June 30, 2021 | 1.093B |
March 31, 2021 | 1.091B |
December 31, 2020 | 992.49M |
September 30, 2020 | 700.47M |
June 30, 2020 | 694.16M |
March 31, 2020 | 687.95M |
December 31, 2019 | 681.90M |
September 30, 2019 | 436.42M |
June 30, 2019 | 431.04M |
March 31, 2019 | 425.75M |
December 31, 2018 | 420.55M |
September 30, 2018 | 415.45M |
June 30, 2018 | 439.44M |
March 31, 2018 | 430.81M |
December 31, 2017 | 431.05M |
Date | Value |
---|---|
September 30, 2017 | 31.28M |
June 30, 2017 | 11.22M |
March 31, 2017 | 13.69M |
December 31, 2016 | 16.15M |
September 30, 2016 | 18.60M |
June 30, 2016 | 20.22M |
March 31, 2016 | 20.98M |
December 31, 2015 | 23.40M |
September 30, 2015 | 23.29M |
June 30, 2015 | 25.66M |
March 31, 2015 | 6.38M |
December 31, 2014 | 6.328M |
September 30, 2014 | 6.275M |
June 30, 2014 | 1.621M |
March 31, 2014 | 1.645M |
December 31, 2013 | 1.668M |
September 30, 2013 | 1.69M |
June 30, 2013 | 1.712M |
March 31, 2013 | 1.735M |
December 31, 2012 | 1.757M |
September 30, 2012 | 1.778M |
June 30, 2012 | 1.80M |
March 31, 2012 | 1.821M |
December 31, 2011 | 1.842M |
September 30, 2011 | 1.862M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
431.04M
Minimum
Jun 2019
1.544B
Maximum
Dec 2022
1.012B
Average
1.095B
Median
Sep 2021
Total Long Term Debt (Quarterly) Benchmarks
PTC Therapeutics Inc | 2.098B |
Vertex Pharmaceuticals Inc | 0.00 |
Regenxbio Inc | 0.00 |
CytomX Therapeutics Inc | 0.00 |
Apellis Pharmaceuticals Inc | 93.03M |